The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.
about
Interaction of occupational and personal risk factors in workforce health and safetySignificance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaCell-based therapies of liver diseases: age-related challengesAdvanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upObesity-Related Digestive Diseases and Their PathophysiologyTargeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsModel-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicineHepatitis C virus and hepatocarcinogenesisP21-activated kinase-2 is a critical mediator of transforming growth factor-β-induced hepatoma cell migrationSuppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cellsAlpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinomaHigh expression of polo-like kinase 1 is associated with early development of hepatocellular carcinoma.Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma.HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinoma.MicroRNA binding site polymorphisms as biomarkers in cancer management and research.Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology.Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.Viral hepatocarcinogenesis.Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.Glypican-3 targeting of liver cancer cells using multifunctional nanoparticlesTemporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 yearsMutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid featuresSingle nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma.Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells.Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis.A polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese populationIntegrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes.The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease.Circulating tumor cells measurements in hepatocellular carcinoma.Contrast-enhanced ultrasonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta-analysis.Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study.The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant IIIX-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysisThe Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia.Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinomaSecond Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria.Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCC.
P2860
Q23919248-A547FC23-3E0E-488B-A2A6-D4574EF8FC5BQ26773251-A6D8EA1C-B4F2-4310-9F33-0D9426306885Q26776328-04D9CA84-0F9E-4EB9-8051-B06439A13C0FQ26851033-01282DDA-D487-4670-8613-3537D9F11347Q28073381-F5E1873D-CB93-4896-88FA-D401D9014B20Q28085015-BFBF8974-5B36-43AB-ACB0-B9624407494CQ28087569-4E78B340-1183-4E99-BE65-3EDBB27C5228Q28283484-FA946750-C32E-4BAC-A7D1-913A281015FEQ28285920-D60E6EC6-5FF1-4FB9-9FAE-27D4CD929934Q28485238-454C3AEF-2DB6-49CC-85C5-A85BBA41CA2AQ33622809-206001E3-DE29-423C-8248-2F4EA6C79860Q33797504-2FDA3FE5-559F-4F83-A5B1-D11B22EA721FQ33820846-F99084EA-288D-48D4-B3F6-528668962C86Q33900599-3AFEBBDA-2A5C-421D-BDDB-AC4506228A4EQ33982230-83FFA39E-4548-4D24-8BD0-FEB7B0ABE352Q34019040-6D23FCA3-7029-4F6B-A0F0-26E1031EC779Q34095605-83E3FCCB-DC6C-4C9B-A1E0-6038B03BDA3EQ34174441-71B6D6B1-404C-4712-BEF6-826FF504A58CQ34307301-ADB96958-1712-4337-95DA-6FC93F197283Q34617749-5F9B21BF-9D52-4066-8640-DE90CF40ACF9Q34619389-C6E4C1AE-6D38-465D-B9C7-DEB65553B629Q34675546-8DCD34DB-7E02-41C0-B348-C13886E253E6Q35047746-3612B52F-535A-40AF-8632-DD786103CB6FQ35129273-3920DBF2-634C-4338-A8D5-3BE3B4371D66Q35133706-934B212B-29B1-45B3-B3C0-5F617E1FA825Q35237526-B2CB1627-157B-4204-86DE-A6E2A80921FFQ35247171-56951148-1A70-49E2-BDB7-EF2FD706EA76Q35507447-D079F025-72FE-4B63-8ED7-6059FC095C7EQ35681537-228DADB8-FB76-422E-A2BC-D8D42F82814CQ35919690-B1CFAF15-2102-4AC4-96C3-7AD74F02E45EQ35984078-E3F8ABF8-1873-4E35-BD1F-8A713E7A2548Q36011412-3AA480B2-61BA-457D-BDEF-89C91D069B52Q36057844-679DD0B4-52DA-4883-85F7-FB8B61B95DE7Q36067582-0B127182-BBE3-4083-883F-5B09FFFDE8F1Q36088178-D2D9458E-DC3C-4037-B1FE-7A359D63D8CBQ36175088-A2B3CFAC-CA67-47DB-8153-151B71EFFB3FQ36197579-4558CEFB-6668-4725-BCD6-190709CB524EQ36224454-03BEBB01-E6E6-4CEF-BC5F-F68B311C59C0Q36359054-5356929A-B471-4AF7-97AB-CCF1A48279D5Q36641420-83FE1B84-BB2B-42A8-8CD0-397EB2B96949
P2860
The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The epidemiology of hepatocell ...... alth problem to tumor biology.
@ast
The epidemiology of hepatocell ...... alth problem to tumor biology.
@en
type
label
The epidemiology of hepatocell ...... alth problem to tumor biology.
@ast
The epidemiology of hepatocell ...... alth problem to tumor biology.
@en
prefLabel
The epidemiology of hepatocell ...... alth problem to tumor biology.
@ast
The epidemiology of hepatocell ...... alth problem to tumor biology.
@en
P1476
The epidemiology of hepatocell ...... alth problem to tumor biology.
@en
P2093
Sang H Park
Stephen Caldwell
P304
P356
10.1007/S00535-008-2258-6
P478
44 Suppl 19
P577
2009-01-16T00:00:00Z